ET
RGNX icon

Entropy Technologies’s Regenxbio RGNX Stock Holding History

Entropy Technologies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
12,128
+1,744
+17% +$14.5K 0.01% 915
2026
Q1 		$87K Buy
+10,384
New +$109K ﹤0.01% 852
2025
Q2 		– Sell
-14,986
Closed -$107K – 985
2025
Q1 		$107K Buy
+14,986
New +$111K 0.01% 669

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Entropy Technologies's RGNX Position: Q2 2026 in Review

Entropy Technologies increased its Regenxbio (RGNX) stake by 17% in Q2 2026, buying an estimated $14.5K and bringing the position to 12,128 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #915.

Entropy Technologies first reported a position in RGNX in Q1 2025 and has held it in 3 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Entropy Technologies held 12,128 shares of Regenxbio worth $145K as of Q2 2026.
  • Entropy Technologies bought 1,744 Regenxbio shares in Q2 2026, an estimated $14.5K.
  • Regenxbio made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #915 holding.
  • Entropy Technologies first reported a position in Regenxbio in Q1 2025 and has held it in 3 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.